Sweden's Ortivus Q1 net sales rise 18%, gross margin improves

Ortivus AB

07/05/2026 07:37

Overview

Sweden healthcare tech firm's Q1 net sales rose 18% yr/yr, gross margin improved to 47%

Company posted positive EBITDA of SEK 1.7 mln vs loss a year ago

Ortivus strengthened liquidity via increased credit facility and divestment of H&E Solutions shares

Outlook

Ortivus did not provide specific financial guidance for the current or future periods

Result Drivers

AI INTEGRATION - Co said it is fully embracing AI in products and internal operations

LIQUIDITY IMPROVEMENT - Liquidity was strengthened by an extended loan from Ponderus Invest and the sale of H&E Solutions shares

Company press release: ID:nMFN7ntQp6

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Sales
SEK 21.50 mln
Q1 Net Income
-SEK 1.30 mln
Q1 Gross Margin
47.00%
Q1 EBITDA
SEK 1.70 mln


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)